Treatment
Estrogen clinical trials
We’re tracking 77 recruiting studies that include Estrogen, each written for real people, not researchers, below.
Recruiting studies
- NCT05586724RecruitingPhase 3
Progesterone vs another hormone added to estrogen for menopause symptoms
This Phase 3 study compares two types of progesterone—micronized progesterone versus norethisterone acetate—both used with estrogen to treat menopause symptoms that affect daily life. It aims to see which combination works better and is tolerated over time for women with an intact uterus.
StockholmAges 45–60 - NCT06544473RecruitingPhase 4
Estrogen pill vs. patch for Turner syndrome
This trial compares oral and transdermal (patch) estrogen to find the right dose for women with Turner syndrome. It aims to see which method works best for hormone replacement.
Aarhus, Aarhus NAges 18–50 - NCT06570460RecruitingPhase 4
Estrogen pills vs. patch for Turner syndrome
This study compares two ways of taking estrogen (pills or a skin patch) in women with Turner syndrome to see which works better over time. It also includes healthy women for comparison.
Aarhus, Aarhus NAges 18–50 - NCT06479720RecruitingPhase 4
Combination medications plus estrogen for overactive bladder
This trial tests whether adding estrogen therapy to a combination of two bladder medications works better than the medications alone for women with overactive bladder that hasn't improved with standard treatment.
TaipeiAges 40–90 - NCT07030426RecruitingPhase 3
Vaginal estrogen before and after prolapse surgery
This trial tests whether using vaginal estrogen before and after prolapse surgery helps improve recovery and long-term results. Women having apical suspension surgery (to support the top of the vagina) may benefit.
St. John's, Newfoundland and LabradorAges 18 years+ - NCT05541367Recruiting
ER PET/CT scan test for breast cancer
This trial studies how well an ER PET/CT scan can image breast cancer. It may help doctors see whether a cancer has estrogen receptor (ER) activity, which can guide treatment planning.
Wuhan, HubeiAges 18 years+ - NCT07865377Recruiting
Resveratrol supplement for heart disease in postmenopausal women
This study tests whether a supplement called resveratrol can positively affect estrogen-related markers in postmenopausal women with stable coronary artery disease. It may help understand how this supplement could support heart health.
São Paulo, São PauloAges 45–70 - NCT07697781Recruiting
Comparing cervical preparation before hysteroscopy in postmenopausal women
This study compares two ways to prepare the cervix before a hysteroscopy (a camera test) in postmenopausal women. It aims to see which method makes the procedure easier and more comfortable.
Tunis, Tunis GovernorateAges Any age - NCT07580846Recruiting
Creatine Supplement for Energy and Strength in Menopausal Women
This 12-week study tests whether a creatine-based nutritional supplement helps menopausal women maintain muscle strength and energy. Creatine is a natural compound that helps muscles work better during exercise.
Madrid, MadridAges 40–75 - NCT07422506Recruiting
Comparing treatments for early missed abortion
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
Changsha, HunanAges 18–40 - NCT07191717RecruitingPhase 2
Imlunestrant and abemaciclib for early ER+ breast cancer
This trial tests whether adding two targeted drugs, imlunestrant and abemaciclib, to your usual hormone therapy can lower the chance of your breast cancer coming back. It is for people with early-stage ER+ breast cancer who have no signs of cancer on scans but have tiny amounts of tumor DNA in their blood (called ctDNA).
Los Angeles, CaliforniaAges 18 years+ - NCT06197295RecruitingPhase 4
Combination therapy for overactive bladder in women
This study compares the effectiveness of a combination of medications (solifenacin and mirabegron) versus solifenacin alone with a vaginal estrogen cream for treating women with overactive bladder. It may help those who haven't improved with single medication.
TaipeiAges 40–90 - NCT06866119Recruiting
Estrogen and heart health in women with early menopause
This study looks at how estrogen therapy affects heart health in women with primary ovarian insufficiency (early menopause). Participants will take a standard estrogen patch and progesterone pill, and researchers will monitor their heart function over time.
Boston, MassachusettsAges 30–40 - NCT06260033RecruitingPhase 2
Radiation Therapy for Oligoprogressive ER+ Breast Cancer
This trial tests whether a precise radiation treatment (SBRT) can target a few growing spots of estrogen receptor-positive breast cancer that has spread to other parts of the body. It also uses a special PET scan (FES PET/CT) to see how well the cancer responds. The goal is to slow down the cancer and delay the need for stronger treatments.
Duarte, CaliforniaAges 18 years+ - NCT05704036RecruitingPhase 4
Estrogen use and bone health in women with cystic fibrosis
This observational study looks at how taking (or not taking) estrogen affects bone health in women with cystic fibrosis (CF). If you may have low estrogen, it also explores whether estrogen levels and symptoms relate to bone density over time.
Baltimore, MarylandAges birth–100 years - NCT03875378RecruitingPhase 2
Transdermal estrogen treatment for anorexia-related bone loss
This trial studies whether estrogen delivered through the skin can help improve bone health in women with anorexia nervosa. It may be considered if your body weight is low and you have signs of bone thinning.
Pittsburgh, PennsylvaniaAges 19–45 - NCT07391774RecruitingPhase 3
Hormone therapy with or without chemo for early breast cancer
This trial tests whether skipping chemotherapy and using only hormone therapy with a drug called ribociclib works as well as chemotherapy followed by hormone therapy with ribociclib for certain early breast cancers that have a low risk of coming back.
Jonesboro, ArkansasAges 18 years+ - NCT04601116RecruitingPhase 3
Atorvastatin for hormone-positive breast cancer to prevent recurrence
This Phase 3 study tests whether taking atorvastatin (a cholesterol-lowering medicine) can improve outcomes for women with estrogen-receptor–positive breast cancer. It may help by affecting cancer-related pathways and reducing risk of recurrence or progression.
AarhusAges 18 years+ - NCT04043520RecruitingPhase 4
Menopause, aging, and energy study
This study looks at how menopause and aging affect the body's energy use. It tests a hormone medication to see how it changes energy levels in healthy women who are recently past menopause.
Aurora, ColoradoAges 40–65 - NCT06590857RecruitingPhase 1/Phase 2
Study of targeted radiation for advanced breast cancer
This trial tests a new type of radiation therapy that targets a specific protein on some breast cancer cells. It may help people whose cancer has stopped responding to other treatments.
Phoenix, ArizonaAges Any age - NCT06264882RecruitingPhase 4
Study on ovarian suppression and body changes
This study looks at how temporarily stopping ovarian function affects weight, body fat, and blood vessel health in premenopausal women. If you qualify, you might help researchers understand the risks and benefits of short-term estrogen suppression.
Aurora, ColoradoAges 20–45 - NCT05221021RecruitingPhase 4
Vaginal estrogen vs oral bladder medicine for overactive bladder
This study compares vaginal estradiol (a hormone placed in the vagina) versus an oral beta-3 medicine called mirabegron for overactive bladder symptoms. It looks to see which treatment works better and is safer for postmenopausal women.
Bethesda, MarylandAges 18 years+ - NCT07649356Recruiting
Estrogen and Muscle Function in Menopausal Women
This study compares how estrogen affects muscle strength and fitness in women before and after menopause. It aims to understand how hormonal changes during menopause impact physical health and may help researchers develop better support for women during this life stage.
AarhusAges 47 years+ - NCT07617454Recruiting
Estrogen and Muscle Gain in Postmenopausal Women
This study looks at how estrogen affects muscle growth when postmenopausal women exercise for 12 weeks. Researchers want to understand whether estrogen plays a role in helping muscles develop stronger during strength training.
Aarhus, JutlandAges 40 years+
What Estrogen is being studied for
Conditions with recruiting Estrogen studies.
Common questions
- Are there clinical trials studying Estrogen?
- Yes. Clin2 currently lists 77 recruiting studies that include Estrogen, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Estrogen trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Estrogen an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Estrogen or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.